RWE GENESYSResource HubPublications

Publications

We present a sample of our own publications, along with monthly highlighted publications from across the globe. Scroll down to discover more…

Big Data: transforming drug development and health policy decision making

Alemayehu, D. and Berger, M, (2016)

Big Data: transforming drug development and health policy decision making

Health Services and Outcomes Research Methodology, 16:92–102

View
Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to Value

Chen et al., (2016)

Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to Value

Journal of Personalized Medicine, 6, 20

View
Adding non-randomised studies to a Cochrane review brings complementary information for healthcare stakeholders: an augmented systematic review and meta-analysis

Arditi, C. et al., (2016)

Adding non-randomised studies to a Cochrane review brings complementary information for healthcare stakeholders: an augmented systematic review and meta-analysis

BMC Health Services Research, 16:598

View
UK Registry for Botulinum Toxin Type A use in cosmetic practice

Jandhyala, R., (2015)

UK Registry for Botulinum Toxin Type A use in cosmetic practice

Journal of Aesthetic Medicine, 1(1):1-5

View
Dermal fillers for facial rejuvenation: a review of clinical evidence

Jandhyala, R., (2015)

Dermal fillers for facial rejuvenation: a review of clinical evidence

Journal of Aesthetic Medicine, 1(1):6-13

View
Personal selling and its effectiveness in generating sales: an assessment of: ‘promotional’, ‘non–promotional’ personal selling and ‘non–‐personal’ selling as part of the Promotional Mix in the Pharmaceutical Industry

Jandhyala, R., (2015)

Personal selling and its effectiveness in generating sales: an assessment of: ‘promotional’, ‘non–promotional’ personal selling and ‘non–‐personal’ selling as part of the Promotional Mix in the Pharmaceutical Industry

MBA Thesis Article

View
Extracorporeal Photopheresis for Second-Line Treatment of Chronic Graft-versus-Host Disease: Results from a Health Technology Assessment in Italy

Waure De C., et al., (2015)

Extracorporeal Photopheresis for Second-Line Treatment of Chronic Graft-versus-Host Disease: Results from a Health Technology Assessment in Italy

Value in Health, 18:457-466

View
From Request to Delivery PhUse Conference 2015

Mewes, K. and Jandhyala, S., (2015)

From Request to Delivery PhUse Conference 2015

Paper DH07

View
Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey

Longworth et al., (2014)

Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey

Health Technology Assessment, Feb;18(9):1-224

View
TECS CASE STUDY 002: Using telemedicine to reduce hospital admissions

NHS England, (2014)

TECS CASE STUDY 002: Using telemedicine to reduce hospital admissions

Airedale Hospital NHS Foundation Trust

View
Efficacy of Rapid-Onset Oral Fentanyl Formulations vs. Oral Morphine for Cancer-Related Breakthrough Pain: A Meta-Analysis of Comparative Trials

Jandhyala, R., (2013)

Efficacy of Rapid-Onset Oral Fentanyl Formulations vs. Oral Morphine for Cancer-Related Breakthrough Pain: A Meta-Analysis of Comparative Trials

Journal of Pain and Symptom Management, Oct;46(4):573-80

View
Improving consent procedures and evaluation of treatment success in cosmetic use of IncobotulinumtoxinA: An Assessment of the Treat-to-Goal Approach

Jandhyala, R., (2013)

Improving consent procedures and evaluation of treatment success in cosmetic use of IncobotulinumtoxinA: An Assessment of the Treat-to-Goal Approach

Journal of Drugs in Dermatology, Jan 1;12(1):72-8

View
Impact of Botulinum Toxin A on the quality of life of subjects following treatment of facial lines

Jandhyala, R., (2013)

Impact of Botulinum Toxin A on the quality of life of subjects following treatment of facial lines

Journal of Clinical Aesthetic Dermatology, Sep;6(9):41-5

View
Various formulations of oral transmucosal fentanyl for breakthrough cancer pain: an indirect mixed treatment comparison meta-analysis

Jandhyala, R., (2012)

Various formulations of oral transmucosal fentanyl for breakthrough cancer pain: an indirect mixed treatment comparison meta-analysis

BMJ Supportive Palliative Care Sep;6(9):41-5

View
Relative potency of incobotulinumtoxin A vs onabotulinumtoxin A, a meta-analysis of key evidence

Jandhyala, R., (2012)

Relative potency of incobotulinumtoxin A vs onabotulinumtoxin A, a meta-analysis of key evidence

Journal of Drugs in Dermatology, Jun;11(6):731-6

View
Effectiveness of Type A Botulinum Toxins for aesthetic indications and their relative economic impact

Jandhyala, R., (2012)

Effectiveness of Type A Botulinum Toxins for aesthetic indications and their relative economic impact

Journal of Plastic Reconstructive and Aesthetic Surgeons, Jun;65(6):720-31

View
Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological Overview

Golder et al., (2011)

Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological Overview

PLoS Medicine, May; 8(5)

View
Evaluating Translational Research: A Process Marker Model

Trochim, W. et al., (2011)

Evaluating Translational Research: A Process Marker Model

Clinical and Translational Science, Jun;4(3):153-62

View

REACH OUT TODAY

Arrange a call back...

Please leave this field empty.
curve
curve

Latest News

RWE Genesys sponsor conference session at 4th Annual Pharmacon Asia 2017,  19-22 September, One Farrer Hotel & Spa, Singapore

RWE Genesys sponsor conference session at 4th Annual Pharmacon Asia 2017, 19-22 September, One Farrer Hotel & Spa, Singapore

Read
Nanoparticles are changing the face of biomedical research

Nanoparticles are changing the face of biomedical research

Read
Economist Report: A chance finding may lead to a treatment for multiple sclerosis

Economist Report: A chance finding may lead to a treatment for multiple sclerosis

Read
Colette Hamilton is an approved speaker on leveraging real world evidence at the Pharma Market Access and Pricing Summit Asia in Singapore 20/21 September 2017

Colette Hamilton is an approved speaker on leveraging real world evidence at the Pharma Market Access and Pricing Summit Asia in Singapore 20/21 September 2017

Read